Baseline predictors of disease severity in immune checkpoint inhibitor-induced inflammatory arthritis.

Cappelli, Laura C; Kamal, Omer; Jones, Michelle; Bingham, Clifton O; Shah, Ami A

Cappelli, Laura C; Kamal, Omer; Jones, Michelle; Bingham, Clifton O; Shah, Ami A.

Afiliación

Cappelli LC; Johns Hopkins Division of Rheumatology, Baltimore, MD, USA.
Kamal O; St. Agnes Hospital, Baltimore, MD, USA.
Jones M; Johns Hopkins Division of Rheumatology, Baltimore, MD, USA.
Bingham CO; Johns Hopkins Division of Rheumatology, Baltimore, MD, USA.
Shah AA; Johns Hopkins Division of Rheumatology, Baltimore, MD, USA.

Rheumatology (Oxford) ; 2023 Aug 30.

Article en En | MEDLINE | ID: mdl-37647635

Palabras clave

cancer; immune checkpoint inhibitor; immunotherapy; inflammatory arthritis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Rheumatology (Oxford) Asunto de la revista: REUMATOLOGIA Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google